These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2458783)

  • 1. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy.
    Aruoma OI; Bomford A; Polson RJ; Halliwell B
    Blood; 1988 Oct; 72(4):1416-9. PubMed ID: 2458783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry.
    Jakeman A; Thompson T; McHattie J; Lehotay DC
    Clin Biochem; 2001 Feb; 34(1):43-7. PubMed ID: 11239514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic hemochromatosis: serum ferritin concentrations during therapy by phlebotomy.
    Garry PJ; Saiki JH
    Clin Chem; 1982 Aug; 28(8):1806-8. PubMed ID: 7094303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.
    Pootrakul P; Josephson B; Huebers HA; Finch CA
    Blood; 1988 Apr; 71(4):1120-3. PubMed ID: 3355890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of serum ferritin in the management of idiopathic haemochromatosis.
    Batey RG; Hussein S; Sherlock S; Hoffbrand AV
    Scand J Gastroenterol; 1978; 13(8):953-7. PubMed ID: 725519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.
    Van Der Weyden MB; Fong H; Salem HH; Batey RG; Dudley FJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):752-4. PubMed ID: 6402233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis.
    Beamish MR; Walker R; Miller F; Worwood M; Jacobs A; Williams R; Corrigall A
    Br J Haematol; 1974 Jun; 27(2):219-28. PubMed ID: 4843672
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis.
    Gutteridge JM; Rowley DA; Griffiths E; Halliwell B
    Clin Sci (Lond); 1985 Apr; 68(4):463-7. PubMed ID: 2578915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-transferrin-bound serum iron in idiopathic hemochromatosis.
    Batey RG; Lai Chung Fong P; Shamir S; Sherlock S
    Dig Dis Sci; 1980 May; 25(5):340-6. PubMed ID: 7371472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferritin in erythrocytes and plasma of patients with iron overload.
    Bodemann HH; Tanzi-Fetta RF; Schröter-Urban H; Volk BA; Keul J; Löhr GW
    Blut; 1985 Jul; 51(1):25-31. PubMed ID: 3848335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
    Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
    Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of hereditary hemochromatosis.
    Valberg LS; Ghent CN
    Annu Rev Med; 1985; 36():27-37. PubMed ID: 3888053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.
    Jacobs A; Miller F; Worwood M; Beamish MR; Wardrop CA
    Br Med J; 1972 Oct; 4(5834):206-8. PubMed ID: 5082548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.
    Grootveld M; Bell JD; Halliwell B; Aruoma OI; Bomford A; Sadler PJ
    J Biol Chem; 1989 Mar; 264(8):4417-22. PubMed ID: 2466835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic iron clearance from serum in treated hemochromatosis.
    Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV
    Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the clinical use of hemochromatosis genetic testing.
    Lanktree MB; Lanktree BB; Paré G; Waye JS; Sadikovic B; Crowther MA
    Can J Gastroenterol Hepatol; 2015; 29(1):41-5. PubMed ID: 25706573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin in haemochromatosis: changes in the isoferritin composition during venesection therapy.
    Halliday JW; McKeering LV; Tweedale R; Powell LW
    Br J Haematol; 1977 Jul; 36(3):395-404. PubMed ID: 19030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method.
    Loréal O; Gosriwatana I; Guyader D; Porter J; Brissot P; Hider RC
    J Hepatol; 2000 May; 32(5):727-33. PubMed ID: 10845658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status.
    Chow LH; Frei JV; Hodsman AB; Valberg LS
    Gastroenterology; 1985 Apr; 88(4):865-9. PubMed ID: 3838288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of intensive phlebotomy therapy in iron overload by serum ferritin assay.
    van Oost BA; van den Beld B; van Asbeck BS; Marx JJ
    Am J Hematol; 1985 Jan; 18(1):7-12. PubMed ID: 3966464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.